Russell Investments Group
CATX icon

Russell Investments Group’s Perspective Therapeutics CATX Stock Holding History

Russell Investments Group’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$136K Buy
39,862
+31,385
+370% +$119K ﹤0.01% 3332
2026
Q1 		$35.3K Hold
8,477
– – ﹤0.01% 3441
2025
Q4 		$23.3K Buy
8,477
+28
+0.3% +$80 ﹤0.01% 3577
2025
Q3 		$29K Buy
8,449
+5,475
+184% +$20K ﹤0.01% 3479
2025
Q2 		$10.2K Buy
2,974
+1,238
+71% +$3.27K ﹤0.01% 3332
2025
Q1 		$3.7K Sell
1,736
-365
-17% -$1.09K ﹤0.01% 3413
2024
Q4 		$6.7K Buy
+2,101
New +$17.2K ﹤0.01% 3225

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Russell Investments Group's CATX Position: Q2 2026 in Review

Russell Investments Group increased its Perspective Therapeutics (CATX) stake by 370% in Q2 2026, buying an estimated $119K and bringing the position to 39,862 shares worth $136K. The position accounts for ﹤0.01% of the portfolio, ranked #3332.

Russell Investments Group first reported a position in CATX in Q4 2024 and has held it in 7 quarters since. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Russell Investments Group held 39,862 shares of Perspective Therapeutics worth $136K as of Q2 2026.
  • Russell Investments Group bought 31,385 Perspective Therapeutics shares in Q2 2026, an estimated $119K.
  • Perspective Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3332 holding.
  • Russell Investments Group first reported a position in Perspective Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.